Sabadell Asset Management’s Gilead Sciences GILD Stock Holding History

Sabadell Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-63,689	Closed	-$5.55M	–	110
2022 Q4	$5.55M	Hold	63,689	–	–	1.15%	36
2022 Q3	$4.17M	Sell	63,689 -11,340	-15%	-$715K	0.92%	39
2022 Q2	$4.64M	Hold	75,029	–	–	0.98%	32
2022 Q1	$4.58M	Sell	75,029 -34,081	-31%	-$2.18M	0.79%	40
2021 Q4	$7.84M	Buy	109,110 +1,693	+2%	+$117K	1.25%	20
2021 Q3	$7.5M	Buy	107,417 +31,787	+42%	+$2.23M	1.29%	20
2021 Q2	$5.21M	Buy	+75,630	New	+$5.05M	0.9%	30

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabadell Asset Management's GILD Position: Q1 2023 in Review

Sabadell Asset Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 63,689 shares — an estimated $5.55M sold.

Sabadell Asset Management first reported a position in GILD in Q2 2021 and held it in 7 quarters. The position peaked at $7.84M in Q4 2021. 1,736 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Sabadell Asset Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
Sabadell Asset Management sold 63,689 Gilead Sciences shares in Q1 2023, an estimated $5.55M.
Sabadell Asset Management first reported a position in Gilead Sciences in Q2 2021 and held it in 7 quarters.
Sabadell Asset Management's Gilead Sciences position peaked at $7.84M in Q4 2021.
1,736 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Sabadell Asset Management's 13F filing for Q1 2023, filed 23 Jan 2024.